Dietary fat: Dietary fatty acids: Dietary carbohydrate: Diet and genetics
In considering the optimal balance of macronutrients in the context of a symposium on optimal nutrition, two caveats immediately spring to mind. One is that it is beyond the scope of a brief presentation to address issues which are regularly addressed by committees of experts often over several years. A second is the question of 'optimal for which purpose?'; reproduction, lactation, growth, health, ageing or physical activity. For the purposes of the present paper the focus will be on optimal macronutrient balance for health, and the macronutrients dealt with will be fat (excluding n-3 polyunsaturated fatty acids (PUFA)) and carbohydrate, since protein, fibre and n-3 PUFA are dealt with elsewhere in the symposium. By way of concluding this introduction, genetic variation in response to dietary intervention will also be considered as a factor impinging on the concept of optimal nutrition.
Dietary fat and dietary carbohydrate level
Most expert committees (Food and Agriculture Organization/World Health Organization, 1994) which have advised the public on optimal levels of dietary fat have advocated a reduction in the proportion of dietary energy from fat. The benefits are a reduction in plasma levels of both total cholesterol and LDL-cholesterol and a reduction in the risk of developing obesity. There is ample evidence in the literature to show that a reduction in total fat intake lowers blood cholesterol. However, reductions in total fat intake are invariably accompanied by reductions in the intakes of cholesterol-raising saturated fatty acids (SFA). Plasma LDL-cholesterol can readily be reduced without a reduction in fat intake, provided SFA intake is reduced. Thus, if plasma LDL-cholesterol is the chosen end point, dietary fat level is not a critical issue. Indeed, if fatal or nonfatal myocardial infarction is the end point, the data from the Nurses Health Study (n 80 082 adult women) would suggest that there is no difference across quintiles of total fat intake (% energy) in the relative risk of CHD when adjusted for other dietary, lifestyle and clinical variables (Hu et al. 1997) . Moreover, it is argued that a reduction in total fat intake, accompanied by a rise in carbohydrate intake, leads to a rise in plasma triacylglycerol (TAG) and a fall in plasma HDL-cholesterol which, certainly in women, would increase the risk of CHD (Katan et al. 1997) . Consequently it is argued that the level of dietary fat should not be the focus of reduction, but rather the level of cholesterol-raising SFA should be the central public health nutrition message. Two recent studies (Saris et al. 1998; Turley et al. 1998 ) have failed to demonstrate a rise in plasma TAG and a fall in plasma HDL-cholesterol with low-fat high-carbohydrate diets. Turley et al. (1998) rotated thirty-eight healthy subjects through a standard Western-type diet (36 % energy from fat, 43 % energy from carbohydrate) and a highcarbohydrate diet (22 % energy from fat, 59 % energy from carbohydrate), with the subjects given advice on how to select a low-fat high-carbohydrate diet. No significant effect on either plasma TAG or HDL-cholesterol was observed. The authors concluded that their study differed from other studies in that the high-carbohydrate diet was freely selected, which compared with studies which observed a rise in plasma TAG where subjects were given either prepared foods, or formula feeds in metabolic wards. That argument seems somewhat simplistic, since many other studies using similar experimental approaches have noted a rise in plasma TAG where subjects self-selected foods according to advice on how to achieve a low-fat highcarbohydrate diet (Roche & Gibney, 1998) . The concept that the method of achieving a low-fat, high-carbohydrate diet determines the plasma TAG is not supported by a second recent study (W Saris, personal communication) where subjects were each assigned to either a low-fat highcarbohydrate diet (27 % and 53 % energy from fat and carbohydrate respectively, or a control diet (36 % energy from fat, 46 % energy from carbohydrate) and where the experimental low-fat diet was largely achieved by subjects receiving prepared low-fat foods from the investigators. No significant effect on plasma TAG or HDL-cholesterol was noted. Thus, it cannot be stated that in all instances low-fat high-carbohydrate diets will elevate plasma TAG. It may be that the initial level of plasma TAG is of importance. In the study of Turley et al. (1998) and in the CARMEN study (W Saris, personal communication) fasting plasma TAG levels were 1·41 and 1·60 mmol/l respectively. However, in the case of Roche & Gibney (1996) and Mensink & Katan (1987) , where low-fat high-carbohydrate diets significantly elevated plasma TAG levels, the fasting plasma TAG levels were much lower (0·95 and 0·86 mmol/l respectively). Clearly, it is a matter of importance in nutrition policy development to clarify the factors which determine plasma TAG responsiveness to low-fat high-carbohydrate diets.
In terms of influence on body weight, there is extensive experimental and epidemiological evidence that high-fat diets predispose to obesity (Gibney, 1995; Prentice & Poppitt, 1996) . However, a counter-argument to this evidence is that whereas obesity levels have increased by 30 % in the USA between 1976 and 1986, total % energy from fat has actually fallen. These arguments are somewhat incomplete if the issue of physical activity is not considered, since Prentice & Jebb (1995) have elegantly demonstrated that the rise in obesity in the UK parallels a rise in sedentary lifestyle, as indicated by the long periods spent watching television and videos, and the numbers of cars per household. It may well be that above a certain level of dietary fat, which may indeed be about the level now prevailing in the USA, physical inactivity is the primary cause of weight gain. Those researchers who argue against a role of high-fat diets in the development of obesity have presented data showing that long-term adherence to a low-fat diet leads to weight losses of only 0·8-2·6 kg (Katan et al. 1997) . However, small changes in mean population body weight may be associated with a significant shift in extremes of the distribution of weight in an environment with a moderately-high level of dietary fat and low level of physical activity. As to the optimum level of total fat in the diet, further research is needed to explore why in some studies, but not others, a low-fat diet induces elevated plasma TAG and reduced HDL concentrations. If a low-fat diet includes a low level (approximately 1·0 g/d) of n-3 long-chain PUFA, then the TAG-raising effects of lowfat high-carbohydrate diets are negated (Roche & Gibney, 1996) . However, unless nutrition policy can successfully raise n-3 PUFA levels, it is necessary to continue to debate the advantages and disadvantages of low-fat diets and to continue to research this complex issue.
Genes, dietary fat and obesity
In addition to diet and physical activity, a third dimension to the debate of lifestyle and body weight is genetics. Saltzman et al. (1997) studied the effects of low-fat and high-fat diets on energy intake and substrate oxidation in a strictlycontrolled study over 9 d in seven pairs of identical twins. It is important to note that both the low-and high-fat diets were of equal energy density. In the case of three twin pairs there was an increase in energy intake with the high-fat diet over the low-fat diet. In three twin pairs the opposite was seen, and with one twin pair no effect of dietary fat on energy intake was noted. Although this was a study where a small group of identical twins were subject to detailed metabolic investigation, it is supported in the provision of evidence for a genetic susceptibility to overeating on a highfat diet, leading to obesity, by a prospective epidemiological study of 361 Swedish women over 12 years of follow-up (Heitmann et al. 1995) . Mean overall BMI gain was just under 1 kg/m 2 . However, the subjects were divided into those who were overweight (BMI 29 kg/m 2 ) and those who were normal weight (BMI 22 kg/m 2 ) at baseline, and each of these groups were further subdivided into those with at least one parent overweight and those with no parents overweight. Increasing dietary fat intake had no effect on BMI in any group other than the one overweight at baseline and with at least one parent overweight. Even then, the elevation in BMI over time occurred only at the 90th percentile of fat intake. Thus, there exists some evidence that obesity may occur with moderately-high-fat diets, and this occurrence of obesity may depend on genetic makeup but almost certainly depends on physical activity levels. Genetic factors may not only play a role in determining the risk of developing obesity, but may also determine the risk of obesity-related morbidity. Thus, Uusitupa et al. (1996) examined fasting plasma insulin levels in women with waist circumferences above or below 1·02 m. In each instance the women were identified for their apolipoprotein (Apo) E phenotype. Those women with the ApoE 3,2 phenotype showed no effect of waist circumference on fasting insulin. In the case of the ApoE 3,3 phenotype, fasting insulin was 33 % higher in women with the higher waist circumference, while in the ApoE 4,3 +4,4 phenotype fasting insulin was doubled with increasing waist size. Clearly, future research will identify further genetic determinants of obesity co-morbidities.
Composition of dietary fat
As indicated in the preceding section, there is ample evidence to show that a reduction in the level of the SFA will reduce LDL-cholesterol, irrespective of dietary fat level. Dietary fatty acid composition is not just relevant to plasma LDL-cholesterol but also to the coagulation system from platelet function to Factor VII activity. Several studies using different approaches have failed to find a role for different dietary fatty acid patterns on different aspects of the coagulation system (Roche & Gibney, 1997; Temme et al. 1998) , while other studies have provided data to suggest that certain aspects of the coagulation pathway are fatty acid-sensitive (Mitropoulos et al. 1994) . To try to examine the role of individual dietary fatty acids in each of these spheres of risk of CHD is too complex an issue, since the relative importance of each of these spheres for CHD cannot be readily established. An alternative approach is to examine epidemiological data where fatal or non-fatal myocardial infarction is the outcome. Hu et al. (1997) examined the independent effects of total, SFA, PUFA and monounsaturated fatty acids (MUFA) on the risk of CHD in a prospective (14-year follow-up) study of 80 082 women. When all lifestyle, clinical and non-lipid dietary variables were controlled for in a multivariate model the following were noted: if 5 % energy from SFA was replaced with 5 % energy from carbohydrates, CHD risk fell by about 15 %; if 5 % energy from SFA was replaced with 5 % energy from MUFA or PUFA, the reductions in CHD risk would be 30 and 45 % respectively. The greatest reduction in CHD risk (> 50 %) was achieved where 2 % energy from transunsaturated fatty acids was replaced with MUFA or PUFA. In effect, the evidence suggests that reducing SFA, and particularly trans-unsaturated fatty acids, by replacement with either MUFA or PUFA while maintaining carbohydrate : fat value constant will provide optimal benefit in terms of CHD.
The two issues of % energy from fat v. fatty acid composition of dietary fats need also to be examined in the context of prevailing patterns of dietary fat intake. Table 1 provides data on the composition of dietary fat in several EU countries at lower and higher levels of dietary fat intake. It is evident that in northern EU countries, the composition of dietary fat remains unchanged, irrespective of the level of dietary total fat. In other words, when populations choose lower-fat diets, they lower their intakes of all categories of fatty acids equally such that fatty acid composition remains unchanged. The same situation is broadly true of southern EU countries. Clearly, the present strategy is tending to favour retention of existing fatty acid patterns, and public health nutrition policy needs to review whether this outcome is a cause for concern.
Genes, dietary fatty acids and plasma cholesterol
It has long been recognized that some individuals respond better than others to dietary and indeed pharmacological intervention for risk-factor reduction. More recently, the contribution of genetics to this variation in response has become clearer. Cox et al. (1995) rotated sixty-seven healthy subjects through high-fat diets (38 % energy from fat) which were either high in PUFA (P diet) or high in SFA (S diet). The subjects followed each diet twice in either an SPSP or PSPS cycle. Of the sixty-seven subjects, twentyfive (37 %) were consistent hyper-responders, twenty-one (31 %) were consistent minimal responders and twenty-one (31 %) were variable responders. Fielding et al. (1995) compared the responses of Caucasians and non-Caucasians to diets high (600 mg) or low (200 mg) in dietary cholesterol, where each of these diets was subdivided into a high (0·8) or low (0·30) PUFA:SFA value. At low levels of dietary cholesterol, the dietary PUFA:SFA value made no difference to non-Caucasians in terms of plasma cholesterol. At higher cholesterol levels in the diet, the plasma cholesterol response differed slightly in the non-Caucasians consuming the low PUFA:SFA (increased by 0·28 mmol/l) and the high PUFA:SFA (increased by 0·41 mmol/l) diets. However, the corresponding values for Caucasians on the high cholesterol intake were increases of 0·47 and 0·78 mmol/l. Both studies indicate within and between ethnic group variation in respect of their response to the effects of dietary fat variation on plasma cholesterol. Moving from ethnic variation to genetic variation, Ordovas et al. (1995) have reviewed the effect of ApoE phenotype on dietary intervention to lower LDL-cholesterol. Four studies showed no effect of ApoE 4 phenotype where the only dietary change was in cholesterol level. In contrast ApoE 4 phenotype compared with non-ApoE 4 phenotypes showed significantly Pajukanta et al. (1996) studied eighty-seven subjects on a low-fat diet (24 % energy from fat) with a low level of SFA (7 % energy from fat). Of the subjects 89 % had the ApoB signal peptide (del/del) polymorphism, and this group showed no response in terms of LDL-or HDL-cholesterol to a low-fat low-SFA diet. Approximately 15 % of subjects had the X + /X + ApoB (X bal) polymorphism, and these subjects did not respond in terms of blood lipids (HDL and LDL) to the low-fat low-SFA diet. Humphries et al. (1996) found that the H − H − (Hind III) polymorphism of lipoprotein lipase (EC 3.1.1.34) led to a 50 % higher response to a high-SFA diet than those with the H + H + allele. Clearly, as our understanding of the genetic determinants of dietary intervention to improve plasma lipid increases, the efficacy of clinical nutrition intervention will improve. However, it is unlikely to influence public health nutrition programmes.
Composition of dietary carbohydrate
The two main dietary carbohydrates are starch and sucrose. Conventional wisdom held starch to be the nutritionally more favourable of the two carbohydrate sources, but when the two sources are compared in experimental and epidemiological studies, this conventional wisdom is shown to be unjustified. Van Dokkum et al. (1991) studied the effect of low-fat, high PUFA:SFA diets with either 15 or 21 % energy from sugars and found both to be equally effective in lowering plasma total, LDL-and HDL-cholesterol. More recently, the multi-centre CARMEN study compared lowfat diets where starch : sugar value was varied (W Saris, unpublished results). They found no significant differences between the two diets over a 6-month period in terms of effects on blood lipids or body weight. Both diets were equal in their cholesterol-lowering weight-reducing properties. Several studies have shown that % energy from dietary fat and dietary sugars are inversely proportional (Gibney, 1990; Bolton-Smith & Woodward, 1994 ) and the latter authors have shown clearly that as % energy from sugar falls and % energy from fat rises, the incidence of obesity rises. As the relative contributions of fat and sugar vary, the level of starch remains constant, as indeed do levels of micronutrients. Flynn et al. (1996) have used UK dietary data to show that about 80 % energy is provided from staple foods (bread, cereals, rice, potatoes, pasta, meat, poultry, fish, fruit and vegetables) and that these staple foods provide > 95 % of most micronutrient intake. The remaining 20 % energy is provided by pure-fat zero-sugar foods (fats, oils) and by pure-sugar zero-fat foods (sugar, soft-drinks and sugar confectionery). Individuals move along the sugar-fat see-saw according to their taste preferences, without any effect on protein, starch, fibre or micronutrient levels in their diet. Thus, there seems little justification for providing any advice to specifically alter the present sugar: starch balance in the diet.
Conclusion
The single biggest requirement for improving macronutrient balance is to lower intakes of SFA and trans-unsaturated fatty acids. Whether this reduction should be accompanied by a reduction in fat intake is still a subject for debate. At present there seems little evidence to suggest that the starch : sugar value in Western diets should be altered.
